Related Experiment Video
Updated: Aug 10, 2026
11:08
Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
Published on: June 22, 2012
Hydroxyurea: an overview
1Bristol-Myers Squibb Immunology, Plainsboro, NJ 08540, USA. michael.stevens@bms.com
Journal of Biological Regulators and Homeostatic Agents
|November 24, 1999
Summary
Hydroxyurea is a versatile drug used for various conditions, including myeloproliferative and neoplastic diseases. Its potential in treating Human Immunodeficiency Virus (HIV) is under investigation, with careful management of side effects.
Area of Science:
- Pharmacology
- Hematology
- Oncology
Background:
- Hydroxyurea has a long history of clinical use for over a century.
- It is a small molecule with diverse biological properties.
- Its applications span myeloproliferative, neoplastic, and non-hematological diseases.
Purpose of the Study:
- To review the established and emerging applications of hydroxyurea.
- To highlight its potential role in Human Immunodeficiency Virus (HIV) treatment.
- To discuss the management of its associated toxicities.
Main Methods:
- Literature review of hydroxyurea's properties and clinical uses.
- Analysis of its efficacy and safety profile in various diseases.
- Examination of its pharmacokinetic and pharmacodynamic characteristics.
Main Results:
- Hydroxyurea is effective in treating a range of hematological and neoplastic conditions.
- Emerging research suggests potential benefits in Human Immunodeficiency Virus (HIV) therapy.
- Dose-related bone marrow suppression is a primary toxicity, managed by dose titration.
Conclusions:
- Hydroxyurea remains a valuable therapeutic agent due to its efficacy, ease of administration, and low cost.
- Careful consideration of its use in pregnancy and during breastfeeding is essential.
- Ongoing research may expand its clinical utility, particularly in Human Immunodeficiency Virus (HIV) treatment.
More Related Videos
Related Concept Videos
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
01:15Renal Drug Excretion: Overview
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
01:06Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:17Oral Hypoglycemic Agents: Sulfonylureas
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...